Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of the Addition of Sufentanil to Interscalene Block in Shoulder Surgery

NCT01025102 is registered in ClinicalTrials.gov with Bent Gymoese Jorgensen as lead sponsor.

NCT NCT01025102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01025102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of the Addition of Sufentanil to Interscalene Block in Shoulder Surgery
Lead sponsor
Bent Gymoese Jorgensen
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2010
Completion date
December 31, 2012
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative pain, shoulder surgery